Opioid REMS: Industry Group Would Add Communication Plan To FDA's Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
MedGuides for three types of long-acting opioids are more practical than a single document, sponsors tell FDA and advisory committee.